To date, there are four COVID-19 vaccines authorized by the Institute of Public Health to use in Chile, that of Pfizer / BioNTech, Sinovac, AstraZeneca / University of Oxford and CanSino. As with all vaccines and pharmaceutical products, in Chile safety of COVID-19 vaccines is continuously monitored and the benefits of its use against possible risks is a permanent activity. In context of this, CAVEI has issued recommendations of immunization strategies against the occurrence of events supposedly attributable to vaccination and immunization (ESAVI) of COVID-19 vaccines used in Chile or of special interest to Chile.

  • Recommendation
  • Americas
  • Chile
  • COVID-19